Phase I multiple-dose trial of inhaled ALN RSV01 in volunteers.

Trial Profile

Phase I multiple-dose trial of inhaled ALN RSV01 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2007

At a glance

  • Drugs Asvasiran sodium (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 14 Dec 2007 Results have been presented at the 18th Annual Drug Delivery to the Lungs meeting in December 2007.
    • 14 Dec 2007 Status changed from in progress to completed.
    • 15 Nov 2007 Enrolment has been completed and safety results are expected at the end of 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top